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Abstract: Dietary polyphenol intake is associated with improvement of metabolic disturbances.
The aims of the present study are to describe dietary polyphenol intake in a population with metabolic
syndrome (MetS) and to examine the association between polyphenol intake and the components
of MetS. This cross-sectional analysis involved 6633 men and women included in the PREDIMED
(PREvención con DIeta MEDiterranea-Plus) study. The polyphenol content of foods was estimated
from the Phenol-Explorer 3.6 database. The mean of total polyphenol intake was 846 ± 318 mg/day.
Except for stilbenes, women had higher polyphenol intake than men. Total polyphenol intake was
higher in older participants (>70 years of age) compared to their younger counterparts. Participants
with body mass index (BMI) >35 kg/m2 reported lower total polyphenol, flavonoid, and stilbene
intake than those with lower BMI. Total polyphenol intake was not associated with a better profile
concerning MetS components, except for high-density lipoprotein cholesterol (HDL-c), although
stilbenes, lignans, and other polyphenols showed an inverse association with blood pressure, fasting
plasma glucose, and triglycerides. A direct association with HDL-c was found for all subclasses
except lignans and phenolic acids. To conclude, in participants with MetS, higher intake of several
polyphenol subclasses was associated with a better profile of MetS components, especially HDL-c.
Keywords: polyphenols; metabolic syndrome; Mediterranean diet; glignans; stilbenes;
HDL-cholesterol
1. Introduction
Polyphenols are plant-derived molecules characterized by the presence of one or more aromatic
rings and attached hydroxyl groups [1]. They are classified into five subclasses according to their
chemical structure, including flavonoids and nonflavonoids subclasses defined as phenolic acids,
stilbenes, lignans, and other polyphenols. These bioactive compounds are responsible for some health
and sensory properties of foods, such as bitterness, astringency, and antioxidant capacity. The intake
of phenolic compounds and their food sources is highly variable and depends on dietary patterns,
sex, socioeconomic factors, and the native foods of each region [2]. The Mediterranean diet (MedDiet)
is characterized by a high intake of phenolic compounds because MedDiet interventions promote
the intake of phenolic rich and plant-based products, such as legumes, vegetables, fruits, nuts and
wholegrain cereals, and promote the use of extra virgin olive oil as the main source of fat. It has been
suggested that phenolic compounds are partly responsible for the beneficial effects attributed to the
MedDiet [3].
The metabolic syndrome (MetS) is defined as a cluster of metabolic disturbances, which include
impaired glucose metabolism, elevated blood pressure, and low level of HDL-c, dyslipidemia, and
abdominal obesity [4]. Sedentary lifestyle, smoking, and unbalanced diets are well-known modifiable
risk factors for MetS, and lifestyle interventions in those areas, especially dietary interventions based
on the MedDiet [3–6], might improve this condition. Considering the chronic low-grade inflammation
and oxidative stress observed in MetS, polyphenols are good candidates to improve the condition
because of their antioxidant and anti-inflammatory properties [7]. Moreover, several epidemiological
studies have observed a negative association between polyphenol intake and MetS rates [8]. Regarding
MetS components, an adequate intake of phenolic compounds has been shown to improve lipid profile
and insulin resistance, and decrease blood pressure levels and body weight [8,9].
Despite the fact that phenol-rich dietary patterns are effective in improving some MetS components,
there is no single phenolic compound or extract able to improve all the components of MetS [10].
Nevertheless, given the complexity of MetS and the heterogeneity of polyphenols, more large
randomized trials with MetS patients are needed to evaluate the effect of polyphenol intake in reducing
MetS complications, and whether intake of the different polyphenol subclasses could be associated with
improvements in MetS components, because each subtype has different absorption and metabolism [11].
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Therefore, the aims of our study were firstly to describe polyphenol intake in 6633 participants
with MetS from the PREvención con DIeta MEDiterranea-Plus (PREDIMED-Plus) trial and to identify
the main food sources of polyphenols in those participants, and secondly to examine whether higher
intakes of some polyphenol sub-classes are associated with MetS components in this population.
2. Materials and Methods
2.1. Design of the Study
A cross-sectional analysis of the baseline data of participants included in the PREvención con
DIeta MEDiterranea-Plus (PREDIMED-Plus) study was performed. The profile of the cohort, recruiting
methods, and data collection processes have been described elsewhere [12] and on the website
http://predimedplus.com. The study protocol was approved by the 23 recruiting centers Institutional
Review Boards and registered in 2014 at the International Standard Randomized Controlled Trial
Number registry (http://www.isrctn.com/ISRCTN89898870). All participants provided written informed
consent before joining the study.
2.2. Participants
A total of 6874 subjects were recruited and randomized in the 23 recruiting centers between
September 2013 and December 2016. Primary care medical doctors from primary care centers of
the National Health System assessed potential participants for eligibility. Eligible participants were
men (aged 55–75 years) and women (aged 60–75 years) with overweight or obesity (body mass index
[BMI] ≥27 and <40 kg/m2) and at least three components of MetS according to the comprehensive
definition of the International Diabetes Federation; National Heart, Lung, and Blood Institute; and
American Heart Association (2009) [4]. Exclusion criteria were documented history of cardiovascular
diseases (CVD), having a long-term illness, drug or alcohol use disorder, a BMI of 40 or higher, a
history of allergy or intolerance to extra virgin olive oil or nuts, malignant cancer, inability to follow
the recommended diet or physical activity program, history of surgical procedures for weight loss,
and obesity of known endocrine disease (except for treated hypothyroidism). Of the total sample of
6874 randomized participants, 241 participants were excluded from the current analysis (Figure 1):
53 without food-frequency questionnaire (FFQ) data at baseline, and 188 participants who reported
energy intake values outside the predefined limits (<3347 kJ [800 kcal]/day or >17,573 kJ [4000 kcal]/day
for men; <2510 kJ [500 kcal]/day or >14,644 kJ [3500 kcal]/day for women) [13].
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2.3. Estimation of Dietary Polyphenol Intake
The total dietary polyphenol intake and polyphenol subclasses were obtained at baseline by the
143-item FFQs used in the PREDIMED-Plus study. As described elsewhere [14], dietary polyphenol
intake was estimated following these steps: (1) All foods from the FFQ with no polyphenol content,
or only traces, were excluded; (2) recipes were calculated according to their ingredients and portions
using traditional MedDiet recipes; (3) when an item from the FFQ included several foods (e.g., oranges
and tangerines), the proportion of intake was calculated according to data available in the national
survey; (4) no retention or yield factors were used to correct weight changes during cooking because
this was already taken into account in the FFQ; (5) the polyphenol content in 100 g of each food
item was obtained from the Phenol-Explorer database (version 3.6) [15]; (6) finally, the individual
polyphenol intake from each food was calculated by multiplying the content of each polyphenol by the
daily consumption of each food. Total polyphenol intake was calculated as the sum of all individual
polyphenol intakes from the food sources reported in the FFQ.
The data used to calculate polyphenol intake was obtained by chromatography of all the
phenolic compounds, except proanthocyanidins, the content of which was obtained by normal-phase
high-performance liquid chromatography. In the case of lignans and phenolic acids in certain foods
(i.e., swiss chard, chickpeas, plums, and strawberry jam), data corresponding to chromatography after
hydrolysis was also collected, since these treatments are needed to release phenolic compounds that
could otherwise not be analyzed. Total and polyphenol subclass intakes were adjusted for energy
intake (kcal/day) using the residual method [13].
2.4. Measurements and Outcome Assessment
Data on age, sex, educational levels, anthropometric measurements, dietary habits and
lifestyle were collected at baseline. Anthropometric measurements were measured according to
the PREDIMED-Plus protocol. Weight was recorded with participants in light clothing without shoes
or accessories using a high-quality calibrated scale. Height was measured with a wall-mounted
stadiometer. Waist circumference was measured midway between the lowest rib and the iliac crest.
The BMI was calculated as weight (kg) divided by the square of height (m2).
Physical activity and sedentary behaviors were evaluated using the validated Regicor Short
Physical Activity Questionnaire [16] and the validated Spanish version of the Nurses’ Health Study
questionnaire [17], respectively.
Information related to sociodemographic and lifestyle habits, individual and family medical
history, smoking status, medical conditions, and medication use was evaluated using self-reported
questionnaires. Sociodemographic and lifestyle variables were categorized as follows: age (three
categories: <65, 65–70, or >70 years), educational level (three categories: primary, secondary, or
high school), physical activity level (three categories: low, moderate, or high), BMI (three categories:
27.0–29.9, 30.0–34.9, or ≥35 kg/m2), and smoking status (three categories: never, former, or current
smoker).
Blood samples were collected after overnight fasting. Biochemical analyses were performed to
determine plasma glucose (mg/dL), glycated hemoglobin (%), HDL-c (mg/dL), and triglyceride (mg/dL)
levels using standard laboratory enzymatic methods. Low-density lipoprotein cholesterol (LDL-c;
mg/dL) was calculated using the Friedewald formula whenever triglyceride levels were less than 300
mg/dL. Blood pressure measurements were obtained after the participant had rested for five minutes.
Each measurement was obtained with a validated semiautomatic oscillometer (Omron HEM-705CP),
ensuring the use of the proper cuff size for each participant.
2.5. Statistical Analysis
Descriptive statistics were used to define the baseline characteristics of the participants.
The database used was the PREDIMED-Plus baseline database generated in September 2018.
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Continuous variables are expressed as mean ± SD. Categorical variables are expressed as number (n)
and percentage (%). Comparisons among quartiles of dietary polyphenol intake used the Pearson chi
square test (χ2) for categorical variables or one-way ANOVA for continuous variables. The associations
between dietary polyphenol intake and MetS components were analyzed by linear regression models
to determine differences between quartiles of polyphenol subclass intake. The results of the regression
models are expressed as unstandardized β-coefficients. For regression models, polyphenol and
polyphenol subclasses are expressed as quartiles of energy-adjusted dietary intake. We used robust
variance estimators to account for intra-cluster correlation in all linear models, considering members
of the same household as a cluster. All regression models were adjusted for potential confounders.
Model 1 was adjusted for sex, age, recruiting center, and members of the same household. Model 2
was additionally adjusted for physical activity level, BMI (except for waist circumference criteria),
smoking status, and educational level. We additionally adjusted for anti-diabetic treatment when
assessing glycemia and antihypertensive treatments when assessing blood pressure. Lastly, model 3
was additionally adjusted for total energy intake (continuous, kcal/day), saturated fatty acids (g/day),
and distilled drinks alcohol intake (g/day). In model 3, the analysis of glycemia was additionally
adjusted for dietary simple sugar intake (g/day), whereas the analysis of systolic and diastolic blood
pressures was also adjusted for dietary sodium intake (mg/day). The normality of the continuous
outcomes and standardized residuals was assessed with the Shapiro–Wilk test. Values are shown as
95% confidence interval (CI) and significance for all statistical tests was based on bilateral contrast set
at p < 0.05. The P value for linear trends was computed by fitting a continuous variable that assigned
the median value for each quartile in regression models. The descriptive analyses shown in Tables 1–3
were performed using SPSS software version 22.0 (Chicago, IL, USA) and the regression analysis was
performed using Stata software version 16 (StataCorp LP, College Station, TX, USA).
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Table 1. Baseline characteristic of participants by quartiles of total polyphenol intake.
Q1 (<623, 3 mg/d) Q2 (623.4–799.4mg/d)
Q3 (799.5–1019.2
mg/d)
Q4
(>1019.3 mg/d) p
p for Linear
Trend
n 1658 1658 1660 1657
Age, years 65.2 ± 4.90 64.8 ± 4.87 65.0 ± 4.87 64.9 ± 4.98 0.10 0.19
Women, n (%) 894 (53.9) 845 (51.0) 785 (47.3) 685 (41.3) <0.001 <0.001
Family history of CVD 1, n (%) 659 (39.7) 698 (42.1) 662 (39.9) 678 (40.9) 0.48 0.81
Current smokers, n (%) 197 (11.9) 205 (12.4) 203 (12.2) 216 (13.0) 0.78 0.36
Former smokers, n (%) 647 (39.0) 695 (41.9) 728 (43.9) 800 (48.3) <0.001 <0.001
BMI, kg/m2 32.6 ± 3.46 32.6 ± 3.49 32.6 ± 3.51 32.3 ± 3.31 0.03 0.02
Waist circumference, cm 107.0 ± 9.76 107.4 ± 9.70 107.8 ± 9.75 107.8 ± 9.36 0.06 0.01
Body weight, kg 85.2 ± 12.8 86.2 ± 12.8 87.3 ± 13.3 87.5 ± 12.8 <0.001 <0.001
Glucose, mg/dL 113.4 ± 28.9 113.9 ± 31.0 113.9 ± 29.0 113.0 ± 27.6 0.78 0.71
Glycated hemoglobin, % 6.10 ± 0.88 6.22 ± 2.58 6.25 ± 3.53 6.10 ± 0.88 0.15 0.85
Total-cholesterol, mg/dL 196 ± 38.4 197 ± 37.7 196 ± 37.0 198 ± 42.8 0.59 0.57
HDL-cholesterol, mg/dL 47.6 ± 11.5 48.2 ± 11.7 48.7 ± 12.2 47.9 ± 11.9 0.06 0.32
Medications, n (%)
Antihypertensive agents 1272 (76.7) 1285 (77.5) 1294 (77.9) 1304 (78.7) 0.48 0.46
Colesterol-lowering agents 862 (52.0) 846 (51.0) 858 (51.7) 842 (50.8) 0.97 0.52
Insulin 84 (5.07) 98 (5.91) 67 (4.04) 63 (3.80) 0.01 0.01
Metformin 380 (22.9) 404 (24.4) 383 (23.1) 347 (20.9) 0.13 0.12
Other hypoglycemic drugs 324 (19.5) 331 (20.0) 327 (19.7) 303 (18.3) 0.62 0.35
Aspirin or antiplatelet drugs 246 (14.8) 272 (16.4) 249 (15.0) 271 (16.3) 0.26 0.61
NSAIDS 534 (32.2) 469 (28.3) 484 (29.2) 446 (26.9) 0.01 0.01
Vitamins and minerals 210 (12.7) 184 (11.1) 220 (13.3) 183 (11.0) 0.19 0.11
Sedative or tranquilliser agents 417 (25.1) 416 (25.1) 389 (23.4) 392 (23.7) 0.85 0.31
Hormonal treatment (only women) 42 (2.53) 41 (2.47) 33 (1.99) 38 (2.29) 0.924 0.935
Educational level, n (%) <0.001 <0.001
Primary school 887 (53.6) 854 (51.5) 805 (48.5) 719 (43.4)
Secondary school 468 (28.3) 467 (28.2) 497 (30.0) 481 (29.0)
University and other studies 301 (18.2) 337 (20.3) 356 (21.5) 456 (27.5)
1 Cardiovascular diseases (CVD), body mass index (BMI), high-density lipoprotein-cholesterol (HDL-c) and nonsteroidal anti-inflammatory drugs (NSAIDs). Continue variables are
expressed as mean (± SD). Categorical variables are expressed as number (n) and percentage (%). Comparisons among quartiles of dietary polyphenol intake with Pearson’s chi square test
for categorical variables or one-way ANOVA for continuous variables. For glycated hemoglobine parameter, 9% of participants had no values available. The P value for linear trend was
computed by fitting a continuous variable that assigned the median value for each quartile in regression models.
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Table 2. Contribution (%) of polyphenol subclasses to total polyphenol intake and food sources.
Polyphenol Subclasses Contribution, Mean(mg/d) ± SD, (%)
Polyphenol Contribution as
Aglycones, Mean (mg/d) ± SD, (%) Food Sources (% of Contribution)
Total polyphenols 846 ± 318 620.9 ± 273.5
Flavonoids 491 ± 253, (58.0) 406.3 ± 237.2 (65.44)
 Anthocyanins 43.5 ± 37.8, (5.14) 24.7 ± 21.7 (3.98) Cherries (42.2), red wine (24.1), olives (10.5), strawberries (10.1), grape (9.30), other foods (3.8)
 Chalcones 0.009 ± 0.18, (<0.01) 0.006 ± 0.01 (<0.01) Beer (100)
 Dihydrochalcones 1.72 ± 1.59, (0.20) 0.98 ± 0.91 (0.16) Apples (93.2), fruit juices from concentrate (6.77)
 Dihydroflavonols 2.62 ± 4.92, (0.31) 1.81 ± 3.43 (0.29) Red wine (97.6), white wine (1.80), rosé wine (0.59)
 Catechines 28.1 ± 22.4, (3.32) 27.1 ± 20.7 (4.36) Tea (23.0), red wine (19.2), apples (18.6), chocolate (11.6), peaches (6.0), cocoa powder (3.18), fruit juices fromconcentrate (2.83), other foods (15.6)
 Proanthocyanidins 204± 185, (24.1) 200.7 ± 189.4 (32.32) Chocolate (42.7), apples (20.4), plums (9.53), red wine (7.09), cocoa powder (5.68), strawberries (4.20), other foods(10.4)
 Theaflavin 0.70 ± 1.81, (0.08) 0.57 ± 1.46 (0.09) Tea (100)
 Flavanones 83.2 ± 76.6, (9.83) 58.1 ± 55.0 (9.35) Oranges (71.3), natural orange juice (23.0), fruit juices from concentrate (3.22), other foods (2.09)
 Flavones 73.2 ± 47.4, (8.65) 54.7 ± 32.9 (8.81) Whole-grain bread (30.0), bread (23.6), oranges (21.6), natural orange juice (8.53), artichoke (3.80), other foods (12.5).
 Flavonols 54.0 ± 22.3, (6.40) 35.6 ± 15.3 (5.73) Onions (27.8), spinach (26.7), lettuce (11.9), red wine (6.02), olives (5.10), asparagus (4.93), other foods (17.55)
 Isoflavonoids 0.002 ± 0.004, (<0.01) 0.002 ± 0.003 (<0.01) Beer (100)
Phenolic acids 280 ± 131, (33.1) 164.2 ± 70.8 (26.44)
 Hydroxybenzoic acids 15.5 ± 10.3, (1.83) 20.5 ± 12.4 (3.30) Red wine (21.2), olives (19.9), walnuts (18.1), tea (9.46), swiss chard leaves (6.15), white wine (1.34), other foods (23.8)
 Hydroxycinnamic acids 264 ± 129, (30.9) 141.6 ± 66.8 (22.80) Decaffeinated coffee (37.7), coffee (26.1), plums (5.66), potatoes (5.50), olives (4.21), red wine (1.79), other foods (19.0)
 Hydroxyphenylacetic acids 0.90 ± 1.04, (0.10) 1.16 ± 1.40 (0.19) Olives (87.2), red wine (6.57), beer (3.86), extra virgin olive oil (1.52), white wine (0.65)
 Hydroxyphenylpropanoic acids
0.48 ± 0.65, (0.06) 0.91 ± 1.23 (0.14) Olives (100)
Stilbenes 2.13 ± 3.92, (0.25) 1.78 ± 3.19 (0.29) Red wine (91.9), white wine (3.94), grapes (1.60), rosé wine (1.21), other foods (0.07)
Lignans 1.53 ± 0.56, (0.18) 1.33 ± 0.55 (0.21) Extra virgin olive oil (16.7), seeds (9.84), oranges (9.73), green bean (5.42), pepper (5.32), peaches (4.97), broccoli(4.71), bread (4.48), red wine (4.16), cabbage (2.77), other foods (31.9)
Other polyphenols 70.8 ± 41.5, (8.37) 45.6 ± 27.8 (7.34)
 Alkylmethoxyphenols 0.93 ± 0.87, (0.11) 0.93 ± 0.87 (0.15) Decaffeinated coffee (74.1), coffee (16.2), beers (9.77)
 Alkylphenols 13.7 ± 17.8, (1.62) 13.8 ± 18.5 (2.23) Whole-grain bread (69.1), whole-grain pastries (14.8), breakfast cereals (8.40), pasta (3.29), other foods (4.41)
 Furanocoumarins 0.37 ± 0.38, (0.04) 0.37 ± 0.39 (0.06) Celery stalks (98.3), grapefruit juice (1.7)
 Hydroxybenzaldehydes 0.42 ± 0.65, (0.05) 0.42 ± 0.66 (<0.01) Red wine (78.9), walnuts (14.5), beer (2.61), white wine (1.95), other foods (2.04)
 Hydroxybenzoketones 0.002 ± 0.004, (<0.01) 0.002 ± 0.003 (<0.01) Beer (100)
 Hydroxycoumarins 0.10 ± 0.19, (0.01) 0.09 ±0.18 (<0.01) Beer (73.6), white wine (26.3), cocoa powder (0.10)
 Methoxyphenols 0.13 ± 0.12, (0.01) 0.11 ± 0.12 (0.01) Decaffeinated coffee (81.3), coffee (18.7)
 Naphtoquinones 0.82 ± 1.12, (0.09) 0.84 ± 1.14 (0.14) Walnuts (100)
 Tyrosols 52.4 ± 37.8, (6.19) 30.0 ± 21.2 (4.83) Olives (50.0), extra virgin olive oil (34.8), refined olive oil (5.17), red wine (3.29), other foods (6.74)
 Other 1.96 ± 2.30, (0.23) 0.66 ± 0.54 (0.11) Orange juice (45.4), pears (18.2), coffee (16.0), other fruit juices (9.98), olives (5.86), other foods (4.56)
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Table 3. Energy-adjusted intake of total polyphenol and their main subclasses according to sociodemographic and lifestyle characteristics.
n
Total
Polypenols
(mg/d)
p Flavonoids(mg/d) p
Phenolic
Acids
(mg/d)
p Stilbenes(mg/d) p
Lignans
(mg/d) p
Other
Polyphenols
(mg/d)
p
Total population 6633 846 ± 275 1 491 ± 229 290 ± 127 2.13 ± 3.81 1.53 ± 0.54 70.8 ± 38.5
Men 3424 830 ± 288 <0.001 469 ± 234 <0.001 285 ± 134 0.003 3.00 ± 4.74 <0.001 1.53 ± 0.54 0.933 72.1 ± 42.5 0.006
Women 3209 863 ± 259 515 ± 220 276 ± 118 1.21 ± 2.12 1.53 ± 0.53 69.5 ± 33.7
Age (years)
<65 3530 835 ± 275 0.002 476 ± 230 <0.001 285 ± 128 0.014 2.15 ± 4.03 0.605 1.51 ± 0.54 0.006 70.7 ± 39.2 0.967
65-70 2122 854 ± 271 503 ± 225 276 ± 123 2.07 ± 3.62 1.55 ± 0.52 71.0 ± 38.3
>70 981 866 ± 281 517 ± 228 275 ± 127 2.21 ± 3.40 1.55 ± 0.54 70.8 ± 36.4
BMI (Kg/m2)
<29.9 1762 847 ± 268 0.042 501 ± 225 0.004 272 ± 124 0.006 2.26 ± 3.85 <0.001 1.52 ± 0.49 0.679 69.9 ± 36.8 0.353
30-34.9 3258 852 ± 280 493 ± 232 284 ± 129 2.24 ± 3.90 1.53 ± 0.54 71.5 ± 39.7
>35 1613 831 ± 270 475 ± 226 282 ± 124 1.77 ± 3.57 1.54 ± 0.57 70.5 ± 37.9
Physical activity
level
Low 3953 833 ± 278 <0.001 480 ± 231 <0.001 280 ± 129 0.884 1.85 ± 3.48 <0.001 1.51 ± 0.54 <0.001 70.0 ± 38.5 0.034
Moderate 1253 861 ± 267 503 ± 217 282 ± 123 2.30 ± 3.79 1.55 ± 0.54 71.7 ± 36.6
Active 1408 867 ± 271 510 ± 230 280 ± 123 2.76 ± 4.55 1.58 ± 0.53 72.8 ± 40.0
Educational level
Primary school 3266 834 ± 259 <0.001 482 ± 213 <0.001 278 ± 121 0.070 1.80 ± 3.38 <0.001 1.54 ± 0.55 0.093 70.9 ± 40.2 0.290
Secondary school 1913 840 ± 270 487 ± 227 279 ± 125 2.27 ± 3.98 1.51 ± 0.53 69.9 ± 38.1
University 1450 880 ± 311 517 ± 260 287 ± 139 2.70 ± 4.40 1.55 ± 0.52 72.0 ± 35.0
Smoking status
Current smokers 821 841 ± 296 0.581 455 ± 243 <0.001 311 ± 143 <0.001 2.33 ± 4.43 0.114 1.47±0.53 <0.001 70.5 ± 46.3 0.768
Non-smokers 5812 847 ± 272 496 ± 226 276 ± 123 2.10 ± 3.72 1.54±0.54 70.9 ± 37.3
1 Mean ± Standard deviation. BMI: body mass index. Total and polyphenol subclasses were adjusted for total energy intake using the residual method. Comparison between subcategories
was performed using ANOVA.
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3. Results
The present study was conducted on 6633 participants from the PREDIMED-Plus study. The mean
age was 65.0 ± 4.9 years, and mean BMI was 32.5 ± 3.44 kg/m2. Table 1 shows the main characteristics of
the participants according to quartiles of dietary total polyphenol intake. We observed that participants
included in the highest quartile of polyphenol intake (>1019.3 mg/day) were mainly men and former
smokers with a higher educational level (all three p < 0.001). We observed an inverse trend in the
relationship between polyphenol intake and BMI (p = 0.02), whereas this trend was direct for waist
circumference (p = 0.01) and body weight (p < 0.001). Moreover, fewer participants with insulin and
nonsteroidal anti-inflammatory drug treatment were observed in the highest quartile of polyphenol
intake (both p = 0.01).
Total polyphenol intake was 846± 318 mg/day, of which 58.0% were flavonoids (491± 253 mg/day),
33.1% phenolic acids (280 ± 131 mg/day), and the rest other polyphenols, stilbenes, and lignans (70.8 ±
41.5, 2.13 ± 3.92, and 1.53 ± 0.56 mg/day, respectively). The mean of the total polyphenol aglycone
intake was 620.9 ± 273.5 mg/day. Table 2 shows the contribution (%) of each polyphenol subclass and
polyphenol aglycones. The highest contributor to total polyphenol intake was hydroxycinnamic acids
(30.9%). Regarding flavonoids, flavanols were the main contributors (24.1% from proanthocyanidins,
3.32% catechins, and 0.08% of theaflavins), followed by flavanones (9.83%), flavones (8.65%), flavonols
(6.40%), and anthocyanins (5.14%). Additionally, tyrosols represented 6.19% of the total polyphenol
intake, being the most abundant polyphenol classified within the group of other polyphenols.
The main food sources for each polyphenol subclass are also shown in Table 2. In the case
of flavonoids, the most important contributors to the intake of proanthocyanidins were fruits and
chocolate and its derivatives. Fruits (mainly oranges and orange juice) were the greatest contributors
of flavanones, while vegetables (mainly onion, spinach, and lettuce) were the greatest contributors
of flavones. Red wine, olives, tea, and wholegrain cereals were also important contributors to the
remaining subclasses. Coffee was the most significant contributor of phenolic acids, especially of
hydroxycinnamic acids, followed by olives and red wine. Stilbenes were mainly provided by red
wine (91.9%). Lignans were widely distributed among foods, with extra virgin olive oil, fruits, and
vegetables the main contributors. The main contributors of other polyphenols were olives, olive oil,
cereals, coffee, and alcoholic beverages (mainly beer and red wine).
Table 3 shows the energy-adjusted intake of total polyphenols and the main subclasses by sex,
age, BMI, level of physical activity, educational level, and smoking status. Total polyphenol intake
was significantly higher in women due to their high intake of flavonoids (p < 0.001), whereas men
consumed more phenolic acids (p = 0.003), stilbenes, and other polyphenols. The intake of total
polyphenols, flavonoids, and lignans increased with age (p= 0.002, p< 0.001, and p= 0.006, respectively).
Interestingly, participants with the highest BMI (>35 kg/m2) showed the lowest total polyphenol
(p = 0.042), flavonoid (p = 0.004), and stilbene intake (p < 0.001), whereas phenolic acid intake was
significantly higher in this group (p = 0.006). The level of physical activity was directly associated with
total polyphenol intake (p < 0.001) and with all polyphenol classes except for phenolic acids (p < 0.001
in all cases except p = 0.03 for other polyphenols). Participants with a higher educational level (high
school) showed higher total polyphenol, flavonoid, and stilbene intake (p < 0.001 in all cases). Current
smokers reported a significantly higher intake of coffee than non-smokers (p < 0.001) and, consequently,
showed a significantly higher intake of phenolic acids (p < 0.001). Otherwise, the smokers group
showed significantly lower intake of flavonoids and lignans than their counterparts (p < 0.001, both).
The associations between dietary polyphenol intake and MetS components after full adjustment
are shown in Figure 2. High flavonoid and low phenolic acid intake were associated with lower waist
circumference (p = 0.02 and p < 0.001, respectively). The highest intake of other polyphenols was
significantly and inversely associated with systolic (p = 0.001) and diastolic blood pressure levels
(p = 0.002). An inverse association was found between fasting plasma glucose levels and lignans
(p = 0.04). Positive associations were found between HDL-c levels and all polyphenol classes except
for phenolic acid and lignan intake. Lastly, triglyceride concentration was inversely associated with
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lignans and stilbenes (p = 0.006 and p = 0.004, respectively). Changes in the linear regression models
after adjustment are shown in the Supplementary Table (Supplementary Table S1).
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4. Discussion
In this cross-sectional study of the PREDIMED-Plus study, we showed that high intake of some
polyphenol subclasses was inversely associated with levels of the MetS components. These associations
were especially observed for the subclasses whose contribution to total polyphenol intake was lower,
such as other polyphenols, lignans, and stilbenes. Previous epidemiological studies have investigated
the association between dietary polyphenol intake and MetS components in healthy populations or
those at high risk of CVD, but to our knowledge there are no previous studies on these associations in
subjects previously diagnosed with MetS.
In our study, the polyphenol intake was 846 ± 318 mg/day, and the intake was highest for
flavonoids (58% of total), followed by phenolic acids (33.1%), similar to results of other Spanish
cohorts [14,18]. By contrast, the total polyphenol intake was considerably lower than the intake
observed in Mediterranean countries of the EPIC Study (1011 mg/day) [19], the SU.VI.MAX cohort
study (1193 mg/day) [20], and the data from other studies conducted in non-Mediterranean countries,
such as the UK National Diet and Nutrition Survey Rolling Programme for participants of similar age
(1053 mg/day) [21]. The main noteworthy difference between our results and those of other countries
was the relevant contribution of seeds, olives and olive oil, and red wine [14,20], while coffee, tea, and
cocoa products are the foods most commonly observed in non-Mediterranean countries [22–24].
In addition to the differences observed according to geographical location and dietary habits,
sociodemographic and lifestyle habits significantly influence the quantity and profile of intake of
polyphenol subclasses. The intake of total polyphenols, particularly flavonoids and lignans, increased
with age compared to younger participants (<65 years), although Grosso et al. reported the opposite
observation [23]. In addition, BMI was inversely associated with total polyphenol intake, mainly
with lower flavonoid and stilbene intake. This finding was also reported in the TOSCA.IT and EPIC
studies [19,25].
The intake of polyphenol subclasses has been reported to have an impact on MetS
components [26,27]. Even though flavonoids were the principal contributors of total polyphenol
intake in our study, no associations were found with any of the MetS components, except for an
inverse association with waist circumference. Similar findings were described in the HELENA
study [28], where flavonoid intake was associated with lower BMI. Research on the mechanisms of
action involved in the anti-obesogenic properties of flavonoids suggests that the improvements in
glucose homeostasis are promoted by reducing insulin resistance and decreasing oxidative stress
levels [29]. Phenolic acid intake was associated with higher fasting plasma glucose levels and waist
circumference. These results are opposite from those observed in the HAPIEE cohort study, which
described the beneficial effects of phenolic acid on the overall risk of developing MetS and lowering
blood pressure [30]. Nevertheless, it must be taken into account that the dietary intake of phenolic acids
and total polyphenol in the mentioned study doubled the amount estimated in our results, probably
because of the higher intake of tea and its contribution to phenolic acid intake compared to our study
population [23]. In Mediterranean countries, dietary intake of stilbenes is relatively high compared to
other countries [19], with red wine being their main source (>90%). In this setting, higher stilbene
intake was associated with higher HDL-c levels, but since HDL-c is the best-established cardiovascular
protective factor by alcohol consumption, we cannot exclude that the alcohol content of red wine may
interfere with this result [31]. In the PREDIMED study, the intake of red wine was associated with
improvements in four out of five MetS criteria (i.e., elevated abdominal obesity, low HDL-c levels,
high blood pressure, and high fasting plasma glucose levels) [32]. Other studies also found an inverse
association between abdominal adiposity and stilbene intake, BMI, and waist circumference [30,33]. As
a mechanistic pathway for stilbenes, resveratrol has shown potential anti-obesogenic effects decreasing
adipocyte proliferation while activating lipolysis and β-oxidation [34]. However, the association
with lower body weight and waist circumference observed in the present study and the promising
effects against obesity associated with polyphenol intake observed in other studies were not clinically
relevant [35]. Our results showed an inverse association between fasting glucose and lignans, and
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an increase in HDL-c levels and lower levels of systolic and diastolic blood pressure measurements
for other polyphenols. The same finding was described in a Brazilian cohort for hypertension and
other polyphenols [36]. In contrast with our results, flavonoids, mainly anthocyanins, showed greater
antihypertensive effects in another study [37]. Finally, the association between lignan intake and fasting
glucose levels was not demonstrated to be linked with the diagnosis of type 2 diabetes (T2D) in the
EPIC study [38], but this inverse association aligned with the results observed in the PREDIMED cohort
and PREDIMED-Plus study [39,40]. The potential mechanism of action underlying this association
might be explained by the improvements observed in gut microbiota. This assumption was also
observed in a study of US women [41], showing an inverse association between levels of gut microbiota
metabolites from dietary lignan intake and T2D incidence.
Interestingly, in our study we found an association between intake of all polyphenol subclasses
except phenolic acids and lignans and higher HDL-c levels. These associations were also found with
total polyphenol intake in the TOSCA.IT study in T2D subjects [25] and in a similar cohort of participants
at high cardiovascular risk [42]. We also observed that triglyceride levels were inversely associated
with stilbene and lignan intake. Despite the fact that the antioxidant properties of polyphenols for the
prevention of LDL-c oxidation are well described, the effects of dietary polyphenols on the reduction
of total cholesterol levels or triglycerides are controverted [43].
The major strengths of the present study are its large sample size, the multicenter design, and
the use of the Phenol-Explorer as the most comprehensive food composition database on dietary
polyphenols [15]. In prior studies, the FFQ was validated to evaluate total polyphenol intake in
both clinical and cross-sectional studies [44]. Our study has also some limitations. First, it used a
cross-sectional design which does not allow attributing conclusions to plausible causes. In order to
establish causality, a randomized controlled trial based on the intake of different polyphenol subclasses
should be performed. Second, potential residual confounding and the lack of generalizability of
the results to other populations than middle-aged to elderly people with higher BMI and MetS are
limitations. Third, the use of the FFQ may have led to a misclassification of the exposure due to
self-reported information of food intake and to the fact that some polyphenol-rich foods are grouped
in the same item (e.g., spices). Nevertheless, the FFQ used has been validated in the adult Spanish
population and showed good reproducibility and validity [45]. Fourth, other factors that affect food
polyphenol content, such as bioavailability, variety, ripeness, culinary technique, storage, region, and
environmental conditions, were not collected.
Even though recent research postulates that polyphenols are effective in improving MetS, no
single phenolic compound or food has an impact on all the MetS components, suggesting that healthy
and polyphenol-rich dietary patterns such as the MedDiet may be an adequate strategy for MetS
management. This research might be useful for setting dietary and health counseling for MetS
patients, especially those with low HDL-c levels. The use of a consensus methodology and polyphenol
database might facilitate this in future studies. Future large-scale clinical trials are needed to clarify the
underlying mechanisms of action and establish safe doses for the potential health effects described.
5. Conclusions
This study provides detailed information about the relationship between polyphenol intake and
the components of MetS in a population of overweight or obese adults. Higher intake of all the
subclasses of polyphenols was associated with a better profile of the components of MetS, especially
with HDL-c levels.
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